Discussion on the Choice of Technology Innovation Strategy of Chinese Pharmaceutical Enterprises
Download PDF
$currentUrl="http://$_SERVER[HTTP_HOST]$_SERVER[REQUEST_URI]"

DOI

10.26689/pbes.v2i4.829

Submitted : 2020-11-30
Accepted : 2020-12-15
Published : 2020-12-30

Abstract

Over the past few years, China’s extensive domestic power has been continually enhanced, and the economy, science, and technology are constantly evolving. Thus, people’s living standards have also been significantly improved. In contemporary culture, individuals are increasingly demanding high-quality, safe lives and, on the one side, all regular necessities such as life-related, drug safety is a must attach huge significance. However, the state’s investment in medical care is not particularly large due to the late start of China’s medical industry. As a result, the pharmaceutical equipment of pharmaceutical companies in China still has many problems and there are potential hidden dangers in drug safety. The pharmaceutical companies in China are innovating on this basis. In technology, research and discussion, many problems appear and related solutions are proposed.